Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Mbx Biosciences

Clinical trials sponsored by Mbx Biosciences, explained in plain language.

MBX Biosciences MBX NASDAQ

Biotech developing peptide therapies for endocrine and metabolic disorders.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Completed 3

New Once-Weekly shot shows promise for Long-Term hypoparathyroidism control

Disease control Ongoing

This study looks at the long-term safety of an experimental drug called MBX 2109 for people with hypoparathyroidism, a condition where the body doesn't produce enough parathyroid hormone. About 60 adults who finished a 12-week phase 2 study will receive weekly injections of MBX 2…

Phase: PHASE2 • Sponsor: MBX Biosciences • Aim: Disease control

Last updated Jun 27, 2026 07:56 UTC